Adair Newhall


Adair serves as a director of NeueHealth. He is a Partner at Greenspring Associates and is responsible for sourcing and due diligence efforts on fund, direct and secondary opportunities. Prior to Greenspring Associates, Adair served as a Principal at Domain Associates, LLC from August 2009 until December 2014. Prior to joining Domain Associates, LLC, he worked in the business development group at Esprit Pharma, Inc., where he assisted with multiple product acquisitions and the subsequent sale of the company to Allergan plc. Adair also serves on the board of directors of Crown Laboratories, Inc. and is a board observer at Aetion, Inc. Entrada and Everside Health.  In addition, Adair advises five venture advisory boards for venture capital firms and six passive direct healthcare investments (HilleVax, Imago Biosciences, Kallyope, NGM Bio, Phathom Pharma, PowerVision, ScoutBio, and Tenaya Therapeutics).

Adair holds a Master of Business Administration from the Darden Graduate School of Business Administration at the University of Virginia and his undergraduate degree from the University of Pennsylvania. Adair is a Kauffman Fellow and a co-founder of the UVA Venture Summit.

Back to Leadership